Distribution of intramuscularly administered erythromycin into subcutaneous tissue chambers before and after inoculation with Pasteurella haemolytica.
Distribution of erythromycin into subcutaneous tissue chambers was characterised pharmacokinetically and the effect of Pasteurella haemolytica infection on the extent of penetration was studied. Thermoplastic tissue chambers were implanted subcutaneously in the paralumbar fossae of six calves. Thirty-five days after implantation, the tissue chamber distribution of intramuscularly administered erythromycin (30 mg kg-1) was studied. Chambers were then inoculated with P haemolytica and the tissue chamber pharmacokinetics of erythromycin were again studied. Diffusion of erythromycin into tissue chambers was best described using a two-compartment model with tissue chambers representing a relatively inaccessible compartment. Despite changes in chamber fluid pH, the extent of erythromycin penetration into chambers was not affected by P haemolytica inoculation. Comparison of computer simulated concentration-time curves resulting from different routes of administration revealed that penetration of erythromycin into less accessible sites was more likely to be higher after intravenous administration than after intramuscular administration.
Clarke
C R
CR
Department of Physiological Sciences, College of Veterinary Medicine, Oklahoma State University, Stillwater 74078.
Bourne
D W
DW
Lauer
A K
AK
Barron
S J
SJ
D000818:Animals; D002417:Cattle; D004917:Erythromycin / Q000008:administration & dosage / Q000493:pharmacokinetics* / Q000633:toxicity; D007273:Injections, Intramuscular; D016978:Mannheimia haemolytica / Q000187:drug effects; D008954:Models, Biological; D010326:Pasteurella Infections / Q000097:blood / Q000378:metabolism*; D012867:Skin / Q000378:metabolism; D013997:Time Factors; D014018:Tissue Distribution
D004917:Erythromycin